{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:38:23Z","timestamp":1792795103000,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"DOI":"10.1007\/s00204-026-04596-5","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:08:25Z","timestamp":1792793305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and translational application of a rat-to-human PBPK model for isopropoxate to support forensic exposure reconstruction and risk assessment"],"prefix":"10.1007","author":[{"given":"Yiling","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1204-9165","authenticated-orcid":false,"given":"Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"issue":"6","key":"4596_CR1","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/jps.20073","volume":"93","author":"LM Berezhkovskiy","year":"2004","unstructured":"Berezhkovskiy LM (2004) Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. J Pharm Sci 93(6):1628\u20131640. https:\/\/doi.org\/10.1002\/jps.20073","journal-title":"J Pharm Sci"},{"key":"4596_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jpba.2017.11.017","volume":"149","author":"X Chen","year":"2018","unstructured":"Chen X, Zhang W, Rios S, Morkos MB, Ye X, Li G, Jiang X, Wang Z, Wang L (2018) An HPLC tandem mass spectrometry for quantification of ET-26-HCl and its major metabolite in plasma and application to a pharmacokinetic study in rats. J Pharm Biomed Anal 149:381\u2013386. https:\/\/doi.org\/10.1016\/j.jpba.2017.11.017","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"4596_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70226","volume":"39","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhang X, Sun L, Liu J, Ma L, Wang M, Shi Y, Yang S, Gu J, Zhang H, Zhang S, Wurita A, Hasegawa K (2025) A simple and sensitive HPLC-MS\/MS method for the simultaneous quantitative analysis and pharmacokinetic comparison of four imidazole-derived GABA receptor agonists: etomidate, metomidate, propoxate, and isopropoxate in mouse blood. Biomed Chromatogr 39(11):e70226. https:\/\/doi.org\/10.1002\/bmc.70226","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"4596_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/15563650.2024.2423834","volume":"63","author":"YT Cheung","year":"2025","unstructured":"Cheung YT, Yeung CW, Yu KY, Lau CY, Tong HF, Chong YK (2025) A recent increasing occurrence of etomidate and propoxate\/isopropoxate misuse. Clin Toxicol (Phila) 63(1):65\u201367. https:\/\/doi.org\/10.1080\/15563650.2024.2423834","journal-title":"Clin Toxicol (Phila)"},{"key":"4596_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11040168","author":"GW Choi","year":"2019","unstructured":"Choi GW, Lee YB, Cho HY (2019) Interpretation of non-clinical data for prediction of human pharmacokinetic parameters: in vitro-in vivo extrapolation and allometric scaling. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics11040168","journal-title":"Pharmaceutics"},{"key":"4596_CR6","unstructured":"Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (COFEPRIS) (2024) Gu\u00eda de Orientaci\u00f3n Sobre Toxicocin\u00e9tica: Evaluaci\u00f3n de la Exposici\u00f3n Sist\u00e9mica en Estudios de Toxicidad y Farmacocin\u00e9tica: Orientaci\u00f3n para Estudios de Distribuci\u00f3n Tisular de Dosis Repetidas. M\u00e9xico"},{"issue":"1","key":"4596_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57581-2","volume":"14","author":"Y Ding","year":"2024","unstructured":"Ding Y, Chu NN, Wang R, Qin W, Shi YF, Qian ZZ, Liu B, He Q (2024) Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects. Sci Rep 14(1):7071. https:\/\/doi.org\/10.1038\/s41598-024-57581-2","journal-title":"Sci Rep"},{"key":"4596_CR8","unstructured":"Dravid A (2020) Modelling and Optimization of Biologically and Physiologically Relevant Systems."},{"issue":"4","key":"4596_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.neuropharm.2009.06.014","volume":"57","author":"B Drexler","year":"2009","unstructured":"Drexler B, Jurd R, Rudolph U, Antkowiak B (2009) Distinct actions of etomidate and propofol at beta3-containing gamma-aminobutyric acid type A receptors. Neuropharmacology 57(4):446\u2013455. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.06.014","journal-title":"Neuropharmacology"},{"key":"4596_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1021\/jm00326a017","volume":"8","author":"F Godefroi","year":"1965","unstructured":"Godefroi F, Janssen AJ, Van der Eycken AM, Vanheertum AH, Niemegeers CJ (1965) DL-1-(1-Arylalkyl)imidazole-5-carboxylate Esters. A Novel Type of Hypnotic Agents. J Med Chem 8:220\u2013223. https:\/\/doi.org\/10.1021\/jm00326a017","journal-title":"J Med Chem"},{"issue":"2","key":"4596_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1258\/002367781780958919","volume":"15","author":"CJ Green","year":"1981","unstructured":"Green CJ, Knight J, Precious S, Simpkin S (1981) Metomidate, etomidate and fentanyl as injectable anaesthetic agents in mice. Lab Anim 15(2):171\u2013175. https:\/\/doi.org\/10.1258\/002367781780958919","journal-title":"Lab Anim"},{"issue":"6","key":"4596_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.12116\/j.issn.1004-5619.2023.330901","volume":"39","author":"X Han","year":"2023","unstructured":"Han X, Liu X, Du ML, Xu RL, Li JR, Liu C, Liu WG (2023) UPLC-MS\/MS method for detection of etomidate and its metabolite etomidate acid quantity in blood. J Forensic Med 39(6):564\u2013570. https:\/\/doi.org\/10.12116\/j.issn.1004-5619.2023.330901","journal-title":"J Forensic Med"},{"key":"4596_CR13","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (1994) Harmonised Tripartite Guideline: Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies S3A."},{"key":"4596_CR14","volume-title":"Principles and practice of pharmacology for anaesthetists: intravenous induction agents","author":"DJ Jackson","year":"2008","unstructured":"Jackson DJ, Forte PJ (2008) Principles and practice of pharmacology for anaesthetists: intravenous induction agents, 5th edn. Blackwell, London","edition":"5th edn"},{"issue":"1","key":"4596_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1208\/s12248-009-9088-1","volume":"11","author":"HM Jones","year":"2009","unstructured":"Jones HM, Gardner IB, Watson KJ (2009) Modelling and PBPK simulation in drug discovery. AAPS J 11(1):155\u2013166. https:\/\/doi.org\/10.1208\/s12248-009-9088-1","journal-title":"AAPS J"},{"issue":"2","key":"4596_CR16","first-page":"152","volume":"49","author":"PP Kumar","year":"2012","unstructured":"Kumar PP, Lingappa L, Shah MA, Shaikh FA (2012) Charcoal hemoperfusion for phenytoin intoxication. Indian Pediatr 49(2):152\u2013153","journal-title":"Indian Pediatr"},{"issue":"6","key":"4596_CR17","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1021\/acs.jcim.4c02145","volume":"65","author":"A Leniak","year":"2025","unstructured":"Leniak A, Pietru\u015b W, \u015awiderska A, Kurczab R (2025) From NMR to AI: do we need 1H NMR experimental spectra to obtain high-quality logD prediction models? J Chem Inf Model 65(6):2924\u20132939. https:\/\/doi.org\/10.1021\/acs.jcim.4c02145","journal-title":"J Chem Inf Model"},{"key":"4596_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpba.2019.02.004","volume":"168","author":"ZW Li","year":"2019","unstructured":"Li ZW, Zhang J, Zhang YF, Zuo Z (2019) Role of esterase mediated hydrolysis of simvastatin in human and rat blood and its impact on pharmacokinetic profiles of simvastatin and its active metabolite in rat. J Pharm Biomed Anal 168:13\u201322. https:\/\/doi.org\/10.1016\/j.jpba.2019.02.004","journal-title":"J Pharm Biomed Anal"},{"key":"4596_CR19","unstructured":"Li JJ (2020) Medicinal Chemistry for Practitioners. Chapter 3 Pharmacokinetics (ADME). John Wiley & Sons, New York"},{"issue":"1","key":"4596_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/13880209.2016.1266669","volume":"55","author":"L Liu","year":"2017","unstructured":"Liu L, Yin X, Wang X, Li X (2017) Determination of dihydromyricetin in rat plasma by LC-MS\/MS and its application to a pharmacokinetic study. Pharm Biol 55(1):657\u2013662. https:\/\/doi.org\/10.1080\/13880209.2016.1266669","journal-title":"Pharm Biol"},{"issue":"4","key":"4596_CR21","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.xphs.2020.12.005","volume":"110","author":"S Mathew","year":"2021","unstructured":"Mathew S, Tess D, Burchett W, Chang G, Woody N, Keefer C, Orozco C, Lin J, Jordan S, Yamazaki S, Jones R, Di L (2021) Evaluation of prediction accuracy for volume of distribution in rat and human using in vitro, in vivo, PBPK and QSAR methods. J Pharm Sci 110(4):1799\u20131823. https:\/\/doi.org\/10.1016\/j.xphs.2020.12.005","journal-title":"J Pharm Sci"},{"issue":"1","key":"4596_CR22","first-page":"39","volume":"12","author":"J Max","year":"2025","unstructured":"Max J (2025) Unlocking therapeutic potential: understanding the significance of bioavailability. Am J Drug Deliv Ther 12(1):39","journal-title":"Am J Drug Deliv Ther"},{"issue":"3","key":"4596_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/BF01037956","volume":"25","author":"PJ McNamara","year":"1983","unstructured":"McNamara PJ, Gibaldi M, Stoeckel K (1983) Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significance. Eur J Clin Pharmacol 25(3):407\u2013412","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"4596_CR24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.xphs.2020.10.059","volume":"110","author":"A Mitra","year":"2021","unstructured":"Mitra A, Suarez-Sharp S, Pepin XJH et al (2021) Applications of physiologically based biopharmaceutics modeling (PBBM) to support drug product quality: a workshop summary report. J Pharm Sci 110(2):594\u2013609. https:\/\/doi.org\/10.1016\/j.xphs.2020.10.059","journal-title":"J Pharm Sci"},{"key":"4596_CR25","unstructured":"National Center for Biotechnology Information (2025) PubChem Compound Summary for CID 201927, 1-Methylethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/201927. Accessed 28 Dec 2025"},{"issue":"12","key":"4596_CR26","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/jcph.70092","volume":"65","author":"HQ Nguyen","year":"2025","unstructured":"Nguyen HQ, Crass RL, Chapel S, Kuan HS, Loewen G, Brar S (2025) Population pharmacokinetic and exposure-efficacy analyses of valbenazine in patients with Huntington\u2019s disease: supporting dose selection for chorea management. J Clin Pharmacol 65(12):1777\u20131788. https:\/\/doi.org\/10.1002\/jcph.70092","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"4596_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/00003088-200847040-00004","volume":"47","author":"SA Peters","year":"2008","unstructured":"Peters SA (2008) Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis. Clin Pharmacokinet 47(4):261\u2013275. https:\/\/doi.org\/10.2165\/00003088-200847040-00004","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"4596_CR28","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB (2015) PkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"4596_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.116962","volume":"264","author":"X Qian","year":"2025","unstructured":"Qian X, Zhou L, Wang X, Qiang H, Li J, Xiang P, Yan H (2025) Rapid qualitative and quantitative analysis of etomidate and its structural analogs in blood by UPLC-MS\/MS and application in six forensic cases. J Pharm Biomed Anal 264:116962. https:\/\/doi.org\/10.1016\/j.jpba.2025.116962","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"4596_CR30","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1124\/dmd.115.065920","volume":"43","author":"JE Sager","year":"2015","unstructured":"Sager JE, Yu J, Ragueneau-Majlessi I, Isoherranen N (2015) Physiologically based pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification. Drug Metab Dispos 43(11):1823\u20131837. https:\/\/doi.org\/10.1124\/dmd.115.065920","journal-title":"Drug Metab Dispos"},{"key":"4596_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2025.105914","volume":"163","author":"JN Smith","year":"2025","unstructured":"Smith JN, Tyrrell KJ, Weitz KK, Faber W (2025) A physiologically based pharmacokinetic (PBPK) model to align dosimetry of the isobutyl metabolic series in rats and humans. Regul Toxicol Pharmacol 163:105914. https:\/\/doi.org\/10.1016\/j.yrtph.2025.105914","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"4596_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2174\/1567201818666210617101630","volume":"19","author":"JC Song","year":"2022","unstructured":"Song JC, Meng XY, Yang H, Gao H, Cai MH, Zhang MZ, Yu WF (2022) Obstructive jaundice does not change the population pharmacokinetics of etomidate in patients who underwent bile duct surgery. Curr Drug Deliv 19(5):635\u2013641. https:\/\/doi.org\/10.2174\/1567201818666210617101630","journal-title":"Curr Drug Deliv"},{"issue":"11","key":"4596_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15110745","volume":"15","author":"S Stoeva-Grigorova","year":"2025","unstructured":"Stoeva-Grigorova S, Hvarchanova N, Gancheva S, Eftimov M, Georgiev KD, Radeva-Ilieva M (2025) Differentiation of therapeutic and illicit drug use via metabolite profiling. Metabolites 15(11):745","journal-title":"Metabolites"},{"issue":"9","key":"4596_CR34","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/dta.3869","volume":"17","author":"Y Tang","year":"2025","unstructured":"Tang Y, Xu L, Zhao J, Qian X, Qiang H, Xiang P, Yan H (2025) Metabolic profile of etomidate and its three analogs in zebrafish, human liver microsomes, human urine and hair samples using UHPLC-Q Exactive Orbitrap-HRMS. Drug Test Anal 17(9):1662\u20131674. https:\/\/doi.org\/10.1002\/dta.3869","journal-title":"Drug Test Anal"},{"issue":"1","key":"4596_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98202-w","volume":"15","author":"N Thaoboonruang","year":"2025","unstructured":"Thaoboonruang N, Lohitnavy O, Ya K, Lohitnavy M (2025) Development of a PBPK model of psilocybin\/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans. Sci Rep 15(1):13721. https:\/\/doi.org\/10.1038\/s41598-025-98202-w","journal-title":"Sci Rep"},{"key":"4596_CR36","unstructured":"The Ministry of Public Security of the People's Republic of China (2024) The supplementary list of controlled non-medicinal narcotic drugs and psychotropic drugs. https:\/\/www.mps.gov.cn\/n6557558\/c9621723\/content.html. Accessed 1 February 2026"},{"key":"4596_CR37","unstructured":"United Nations Offices on Drugs and Crime (UNODC) Early Warning Advisory (EWA) (2026) UNODC Early Warning Advisory on NPS, Data Visualisations - Public. https:\/\/www.unodc.org\/LSS\/Page\/NPS\/DataVisualisations. Accessed 30 July 2026"},{"key":"4596_CR38","unstructured":"United Nations Offices on Drugs and Crime (UNODC) (2024) World Drug Report 2023. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html. Accessed May 7, 2024"},{"issue":"2","key":"4596_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40262-024-01444-6","volume":"64","author":"DW van Valkengoed","year":"2025","unstructured":"van Valkengoed DW, Krekels EHJ, Knibbe CAJ (2025) All you need to know about allometric scaling: an integrative review on the theoretical basis, empirical evidence, and application in human pharmacology. Clin Pharmacokinet 64(2):173\u2013192. https:\/\/doi.org\/10.1007\/s40262-024-01444-6","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"4596_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/pharmaceutics14010047","volume":"14","author":"KH Wills","year":"2021","unstructured":"Wills KH, Behan SJ, Nance MJ, Dawson JL, Polasek TM, Hopkins AM, van Dyk M, Rowland A (2021) Combining therapeutic drug monitoring and pharmacokinetic modelling deconvolutes physiological and environmental sources of variability in clozapine exposure. Pharmaceutics 14(1):47. https:\/\/doi.org\/10.3390\/pharmaceutics14010047","journal-title":"Pharmaceutics"},{"key":"4596_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tox.2014.05.006","volume":"332","author":"M Yoon","year":"2015","unstructured":"Yoon M, Kedderis GL, Yan GZ, Clewell HJ (2015) Use of in vitro data in developing a physiologically based pharmacokinetic model: carbaryl as a case study. Toxicology 332:52\u201366. https:\/\/doi.org\/10.1016\/j.tox.2014.05.006","journal-title":"Toxicology"},{"issue":"10","key":"4596_CR42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/17425255.2022.2132931","volume":"18","author":"T Zhang","year":"2022","unstructured":"Zhang T, Krekels EHJ, Smit C, Knibbe CAJ (2022) Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes. Expert Opin Drug Metab Toxicol 18(10):657\u2013674. https:\/\/doi.org\/10.1080\/17425255.2022.2132931","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"4596_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11419-024-00707-y","volume":"43","author":"X Zhang","year":"2025","unstructured":"Zhang X, Chen Y, Liu J, Wang M, Dai Y, Zhao K, Gu J, Zhang H, Wurita A, Hasegawa K (2025) Identification of a novel imidazole-derived GABA agonist isopropoxate: simultaneous detection and quantification of imidazole-derived analogs from human hairs in abused cases by LC-MS\/MS. Forensic Toxicol 43(2):190\u2013205. https:\/\/doi.org\/10.1007\/s11419-024-00707-y","journal-title":"Forensic Toxicol"},{"key":"4596_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2025.117352","volume":"499","author":"L Zhong","year":"2025","unstructured":"Zhong L, Li L, He Q, Zhu X, Xiang P, Xiang X, Yan H (2025) Rat-to-human PBPK model of U-47700: unveiling pharmacokinetic risks of a synthetic opioid through interspecies extrapolation. Toxicol Appl Pharmacol 499:117352. https:\/\/doi.org\/10.1016\/j.taap.2025.117352","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04596-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04596-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04596-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:08:29Z","timestamp":1792793309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04596-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":44,"alternative-id":["4596"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04596-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"30 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}